CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Return
34.55%
This Quarter Return
+11.62%
1 Year Return
+34.55%
3 Year Return
+41.71%
5 Year Return
+124.92%
10 Year Return
+254.42%
AUM
$104B
AUM Growth
+$832M
(+0.8%)
Cap. Flow
-$8.36B
Cap. Flow
% of AUM
-8.01%
Top 10 Holdings %
Top 10 Hldgs %
24.95%
Holding
3,100
New
50
Increased
1,214
Reduced
1,289
Closed
124
Top Buys
| 1 |
iShares MSCI ACWI ETF
ACWI
|
+$198M |
| 2 |
UBS Group
UBS
|
+$115M |
| 3 |
Flutter Entertainment
FLUT
|
+$62.4M |
| 4 |
Eli Lilly
LLY
|
+$53.1M |
| 5 |
Dynatrace
DT
|
+$46.7M |
Top Sells
| 1 |
iShares Russell 2000 ETF
IWM
|
+$525M |
| 2 |
Apple
AAPL
|
+$332M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$296M |
| 4 |
Microsoft
MSFT
|
+$259M |
| 5 |
Amazon
AMZN
|
+$206M |
Sector Composition
| 1 | Technology | 27.94% |
| 2 | Financials | 15.29% |
| 3 | Healthcare | 14.41% |
| 4 | Consumer Discretionary | 9.6% |
| 5 | Industrials | 8.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2276
Pitney Bowes
PBI
$1.97B
| $899K | ﹤0.01% |
207,734
-6,951
| -3% | -$30.1K |
|
2277
Harte-Hanks
HHS
$27.6M
| $898K | ﹤0.01% |
120,000
-6,872
| -5% | -$51.4K |
|
2278
Beyond Meat
BYND
$199M
| $896K | ﹤0.01% |
108,233
+38,583
| +55% | +$319K |
|
2279
Cerence
CRNC
$426M
| $896K | ﹤0.01% |
56,860
+4,765
| +9% | +$75K |
|
2280
Integral Ad Science
IAS
$1.44B
| $895K | ﹤0.01% |
89,809
+16,247
| +22% | +$162K |
|
2281
Acco Brands
ACCO
$372M
| $894K | ﹤0.01% |
159,285
+3,734
| +2% | +$20.9K |
|
2282
Compass Minerals
CMP
$771M
| $893K | ﹤0.01% |
56,766
+4,600
| +9% | +$72.4K |
|
2283
Arcus Biosciences
RCUS
$1.22B
| $893K | ﹤0.01% |
47,298
| – | – |
|
2284
Scholastic
SCHL
$687M
| $893K | ﹤0.01% |
23,669
-1,251
| -5% | -$47.2K |
|
|
INVX
2285
Innovex International, Inc.
INVX
$1.16B
| $890K | ﹤0.01% |
39,516
+351
| +0.9% | +$7.91K |
|
2286
Evolus
EOLS
$486M
| $889K | ﹤0.01% |
63,499
-1,010
| -2% | -$14.1K |
|
2287
RPC Inc
RES
$1.03B
| $888K | ﹤0.01% |
114,708
+7,221
| +7% | +$55.9K |
|
2288
ChargePoint
CHPT
$235M
| $886K | ﹤0.01% |
23,328
-3,733
| -14% | -$142K |
|
|
RVNC
2289
DELISTED
Revance Therapeutics, Inc.
RVNC
| $886K | ﹤0.01% |
180,148
+8,141
| +5% | +$40.1K |
|
2290
Arm
ARM
$164B
| $884K | ﹤0.01% |
7,070
-6,335
| -47% | -$792K |
|
2291
NovaGold Resources
NG
$2.84B
| $883K | ﹤0.01% |
294,200
+18,712
| +7% | +$56.1K |
|
2292
First Advantage
FA
$2.83B
| $882K | ﹤0.01% |
54,396
+2,243
| +4% | +$36.4K |
|
2293
Regenxbio
RGNX
$479M
| $879K | ﹤0.01% |
41,704
| – | – |
|
2294
Vicor
VICR
$2.29B
| $873K | ﹤0.01% |
22,835
| – | – |
|
|
VERV
2295
DELISTED
Verve Therapeutics
VERV
| $873K | ﹤0.01% |
65,742
+2,889
| +5% | +$38.4K |
|
|
FUSN
2296
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| $873K | ﹤0.01% |
+40,935
| New | +$873K |
|
2297
Byline Bancorp
BY
$1.33B
| $868K | ﹤0.01% |
39,986
+2,423
| +6% | +$52.6K |
|
2298
National Presto Industries
NPK
$810M
| $867K | ﹤0.01% |
10,344
| – | – |
|
|
SWI
2299
DELISTED
SolarWinds Corporation Common Stock
SWI
| $866K | ﹤0.01% |
68,651
| – | – |
|
2300
Heidrick & Struggles
HSII
$1.05B
| $866K | ﹤0.01% |
25,728
+88
| +0.3% | +$2.96K |
|